[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621325":3},{"organization":4,"outcomesModule":7,"designInfo":25,"detailedDescription":32,"studyPopulation":24,"armGroups":33,"interventions":40,"overallOfficials":24,"centralContacts":45,"locations":53,"responsibleParty":413,"collaborators":24,"id":415,"slug":24,"hasResults":416,"nctId":417,"briefTitle":418,"officialTitle":419,"acronym":420,"eligibilityCriteria":421,"healthyVolunteers":416,"sex":422,"minAge":423,"maxAge":424,"enrollmentInfo":425,"targetDuration":24,"studyType":428,"phases":429,"briefSummary":431,"conditions":432,"keywords":24,"overallStatus":434,"whyStopped":24,"lastUpdateSubmitDate":435,"lastUpdatePostDateStruct":436,"startDateStruct":439,"completionDateStruct":441,"leadSponsor":443,"locationsCount":444},{"fullName":5,"class":6},"LB Pharmaceuticals Inc.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":24},[9],{"measure":10,"description":11,"timeFrame":12},"Evaluate long term safety and tolerability of LB-102 by evaluating the number of adverse event, incidence of treatment emergent events.","Overall adverse events, serious adverse events, incidence of treatment emergent events and adverse events which lead to study discontinuation","52 weeks",[14,17,19,21],{"measure":15,"description":16,"timeFrame":12},"Evaluate long term safety and tolerability","Evaluating the safety of treatment by number of adverse events",{"measure":15,"description":18,"timeFrame":12},"Evaluating the safety of treatment by change in vital signs, electrocardiogram (QTC), and weight\u002Fheight for BMI",{"measure":15,"description":20,"timeFrame":12},"Evaluating the safety of treatment by conducting physical examinations",{"measure":22,"description":23,"timeFrame":12},"Assess the long-term effectiveness determined by Positive and Negative Syndrome Scale (PANSS)","Change in Positive and Negative Syndrome Scale (PANSS) from Baseline to end of treatment where a decrease in score likely indicate response to treatment whereas an increase in score may indicate a worsening of disease where an increase in the scale score may indicate a worsening of disease and decrease in score likely indicates response to treatment.",null,{"allocation":26,"interventionModel":27,"interventionModelDescription":28,"primaryPurpose":29,"observationalModel":24,"timePerspective":24,"maskingInfo":30},"NA","SINGLE_GROUP","Open label study","TREATMENT",{"masking":31,"maskingDescription":24,"whoMasked":24},"NONE","Phase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizophrenia who are experiencing inadequate response or who are having issues with side effects, general tolerability, or overall effectiveness of their current antipsychotic medication and desire to change medications, or who have completed their participation in current LB-102 clinical studies",[34],{"label":35,"type":36,"description":37,"interventionNames":38},"LB-102","OTHER","An open label study",[39],"Drug: LB-102",[41],{"type":42,"name":35,"description":43,"armGroupLabels":44,"otherNames":24},"DRUG","LB-102 flexible dosing 50 mg - 100 mg",[35],[46,51],{"name":47,"role":48,"phone":49,"phoneExt":24,"email":50},"Anna Eramo, MD","CONTACT","212-605-0300","clinicaltrials@lbpharma.us",{"name":52,"role":48,"phone":49,"phoneExt":24,"email":50},"Branislav Mancevski, MD",[54,75,93,107,118,133,147,162,173,187,206,225,239,253,267,283,298,313,332,346,362,380,400],{"facility":55,"status":24,"city":56,"state":57,"zip":58,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"Chandler Clinical Trials","Chandler","Arizona","85224","United States","US",{"type":62,"coordinates":63},"Point",[64,65],-111.84125,33.30616,{"lat":65,"lon":64},[68,72],{"name":69,"role":48,"phone":70,"phoneExt":24,"email":71},"Anna Mangus","480-716-4590","amangus@chandlertrials.com",{"name":73,"role":48,"phone":70,"phoneExt":24,"email":74},"Lauryn Shearer","lshearer@chandlertrials.com",{"facility":76,"status":24,"city":77,"state":78,"zip":79,"country":59,"countryCode":60,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"Pillar Clinical Research","Bentonville","Arkansas","72712",{"type":62,"coordinates":81},[82,83],-94.20882,36.37285,{"lat":83,"lon":82},[86,90],{"name":87,"role":48,"phone":88,"phoneExt":24,"email":89},"Nicole Gutierrez","479-367-2688","ngutierrez@pillarhc.com",{"name":91,"role":92,"phone":24,"phoneExt":24,"email":24},"Fayz Hudefi, MD","PRINCIPAL_INVESTIGATOR",{"facility":76,"status":24,"city":94,"state":78,"zip":95,"country":59,"countryCode":60,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Little Rock","72204",{"type":62,"coordinates":97},[98,99],-92.28959,34.74648,{"lat":99,"lon":98},[102,105],{"name":103,"role":48,"phone":104,"phoneExt":24,"email":89},"Nichole Gutierrez","501-307-1919",{"name":106,"role":92,"phone":24,"phoneExt":24,"email":24},"Leslie Smith, MD",{"facility":108,"status":24,"city":94,"state":78,"zip":109,"country":59,"countryCode":60,"cosmosGeoPoint":110,"geoPoint":112,"contacts":113},"Woodland International Research Group","72211",{"type":62,"coordinates":111},[98,99],{"lat":99,"lon":98},[114],{"name":115,"role":48,"phone":116,"phoneExt":24,"email":117},"Ashley Poole","501-221-8681","apoole@ergclinical.com",{"facility":119,"status":24,"city":120,"state":121,"zip":122,"country":59,"countryCode":60,"cosmosGeoPoint":123,"geoPoint":127,"contacts":128},"Advanced Research Center","Anaheim","California","92805",{"type":62,"coordinates":124},[125,126],-117.9145,33.83529,{"lat":126,"lon":125},[129],{"name":130,"role":48,"phone":131,"phoneExt":24,"email":132},"Halynn Nguyen","714-999-6688","hnguyen@arctrials.com",{"facility":134,"status":24,"city":135,"state":121,"zip":136,"country":59,"countryCode":60,"cosmosGeoPoint":137,"geoPoint":141,"contacts":142},"Synapse Clinical Trials","Cerritos","90703",{"type":62,"coordinates":138},[139,140],-118.06479,33.85835,{"lat":140,"lon":139},[143],{"name":144,"role":48,"phone":145,"phoneExt":24,"email":146},"Paige Mansfield","949-350-0492","p.mansfield@synapsetrials.com",{"facility":148,"status":24,"city":149,"state":121,"zip":150,"country":59,"countryCode":60,"cosmosGeoPoint":151,"geoPoint":155,"contacts":156},"ProScience Research Group","Culver City","90230",{"type":62,"coordinates":152},[153,154],-118.39647,34.02112,{"lat":154,"lon":153},[157],{"name":158,"role":48,"phone":159,"phoneExt":160,"email":161},"Paola Aguirre","424-227-8127","2","paola.aguirre@proscienceerg.com",{"facility":163,"status":24,"city":149,"state":121,"zip":164,"country":59,"countryCode":60,"cosmosGeoPoint":165,"geoPoint":167,"contacts":168},"CenExel","92845",{"type":62,"coordinates":166},[153,154],{"lat":154,"lon":153},[169],{"name":170,"role":48,"phone":171,"phoneExt":24,"email":172},"Dakota Gainers","714-943-5874","d.gainers@cenexel.com",{"facility":174,"status":24,"city":175,"state":121,"zip":176,"country":59,"countryCode":60,"cosmosGeoPoint":177,"geoPoint":181,"contacts":182},"Synergy San Diego","San Diego","92064",{"type":62,"coordinates":178},[179,180],-117.16472,32.71571,{"lat":180,"lon":179},[183],{"name":184,"role":48,"phone":185,"phoneExt":24,"email":186},"Corey Weise","619-303-6130","cweise@ergclinical.com",{"facility":163,"status":24,"city":188,"state":189,"zip":190,"country":59,"countryCode":60,"cosmosGeoPoint":191,"geoPoint":195,"contacts":196},"Hollywood","Florida","33024",{"type":62,"coordinates":192},[193,194],-80.14949,26.0112,{"lat":194,"lon":193},[197,201,204],{"name":198,"role":48,"phone":199,"phoneExt":24,"email":200},"Anna Molero","954-990-7649","a.molero@cenexel.com",{"name":202,"role":48,"phone":199,"phoneExt":24,"email":203},"Aliarys Alcantara","a.alcantara@cenexel.com",{"name":205,"role":92,"phone":24,"phoneExt":24,"email":24},"Edwin Gomez, MD",{"facility":207,"status":24,"city":208,"state":189,"zip":209,"country":59,"countryCode":60,"cosmosGeoPoint":210,"geoPoint":214,"contacts":215},"Segal Trials","Miami Lakes","33063",{"type":62,"coordinates":211},[212,213],-80.30866,25.90871,{"lat":213,"lon":212},[216,221],{"name":217,"role":48,"phone":218,"phoneExt":219,"email":220},"Melissa Rodco","305-722-8444","6006","mrodco@segaltrials.com",{"name":222,"role":48,"phone":218,"phoneExt":223,"email":224},"Luis Sotolongo","3611","lsotolongo@segaltrials.com",{"facility":226,"status":24,"city":227,"state":189,"zip":228,"country":59,"countryCode":60,"cosmosGeoPoint":229,"geoPoint":233,"contacts":234},"Health Synergy Clinical Research","West Palm Beach","33407",{"type":62,"coordinates":230},[231,232],-80.05337,26.71534,{"lat":232,"lon":231},[235],{"name":236,"role":48,"phone":237,"phoneExt":24,"email":238},"Katherine Grigelis","561-473-3472","kat@hscresearch.com",{"facility":163,"status":24,"city":240,"state":241,"zip":242,"country":59,"countryCode":60,"cosmosGeoPoint":243,"geoPoint":247,"contacts":248},"Atlanta","Georgia","30331",{"type":62,"coordinates":244},[245,246],-84.38798,33.749,{"lat":246,"lon":245},[249],{"name":250,"role":48,"phone":251,"phoneExt":24,"email":252},"Amber Tannahill","404-881-5800","a.tannahill@cenexel.com",{"facility":254,"status":24,"city":255,"state":241,"zip":256,"country":59,"countryCode":60,"cosmosGeoPoint":257,"geoPoint":261,"contacts":262},"Accelerated Clinical Trial","Snellville","30078",{"type":62,"coordinates":258},[259,260],-84.01991,33.85733,{"lat":260,"lon":259},[263],{"name":264,"role":48,"phone":265,"phoneExt":24,"email":266},"Alexis Melson","678-255-1041","amelson@acceleratedclinicaltrials.org",{"facility":76,"status":24,"city":268,"state":269,"zip":270,"country":59,"countryCode":60,"cosmosGeoPoint":271,"geoPoint":275,"contacts":276},"Chicago","Illinois","60641",{"type":62,"coordinates":272},[273,274],-87.65005,41.85003,{"lat":274,"lon":273},[277,278,281],{"name":103,"role":48,"phone":88,"phoneExt":24,"email":89},{"name":279,"role":48,"phone":24,"phoneExt":24,"email":280},"Betty Davis","bdavis@pillarhc.com",{"name":282,"role":92,"phone":24,"phoneExt":24,"email":24},"Roueen Rafeyan, MD",{"facility":284,"status":24,"city":285,"state":286,"zip":287,"country":59,"countryCode":60,"cosmosGeoPoint":288,"geoPoint":292,"contacts":293},"CenExel Gaithersburg","Gaithersburg","Maryland","20877",{"type":62,"coordinates":289},[290,291],-77.20137,39.14344,{"lat":291,"lon":290},[294],{"name":295,"role":48,"phone":296,"phoneExt":24,"email":297},"Evan Covington","301-251-4702","e.covington@cenexel.com",{"facility":299,"status":24,"city":300,"state":301,"zip":302,"country":59,"countryCode":60,"cosmosGeoPoint":303,"geoPoint":307,"contacts":308},"Arch Clinical Trials","St Louis","Missouri","63141",{"type":62,"coordinates":304},[305,306],-90.19789,38.62727,{"lat":306,"lon":305},[309],{"name":310,"role":48,"phone":311,"phoneExt":24,"email":312},"Israa Diab","314-266-1243","idiab@archclinicaltrials.com",{"facility":314,"status":24,"city":315,"state":316,"zip":317,"country":59,"countryCode":60,"cosmosGeoPoint":318,"geoPoint":322,"contacts":323},"Redbird Research","Las Vegas","Nevada","89119",{"type":62,"coordinates":319},[320,321],-115.13722,36.17497,{"lat":321,"lon":320},[324,328],{"name":325,"role":48,"phone":326,"phoneExt":24,"email":327},"Pamela Pioquinto","702-577-200","pamela@redbird-research.com",{"name":329,"role":48,"phone":330,"phoneExt":24,"email":331},"Eline Kalamkaryan","702-577-2000","eline@redbird-research.com",{"facility":333,"status":24,"city":334,"state":334,"zip":335,"country":59,"countryCode":60,"cosmosGeoPoint":336,"geoPoint":340,"contacts":341},"Neuro-Behavioral Clinical Research","New York","11516",{"type":62,"coordinates":337},[338,339],-74.00597,40.71427,{"lat":339,"lon":338},[342],{"name":343,"role":48,"phone":344,"phoneExt":24,"email":345},"Cameron Anthony","516-295-7230","canthony@NBReasearch.com",{"facility":333,"status":24,"city":347,"state":348,"zip":349,"country":59,"countryCode":60,"cosmosGeoPoint":350,"geoPoint":354,"contacts":355},"Canton","Ohio","44720",{"type":62,"coordinates":351},[352,353],-81.37845,40.79895,{"lat":353,"lon":352},[356,360],{"name":357,"role":48,"phone":358,"phoneExt":24,"email":359},"Crystal Blackford","330-493-1118","cblackford@nb-cr.com",{"name":361,"role":48,"phone":358,"phoneExt":24,"email":24},"Nate Fontes",{"facility":363,"status":24,"city":364,"state":365,"zip":366,"country":59,"countryCode":60,"cosmosGeoPoint":367,"geoPoint":371,"contacts":372},"Adams Clinical","Philadelphia","Pennsylvania","19104",{"type":62,"coordinates":368},[369,370],-75.16362,39.95238,{"lat":370,"lon":369},[373,377],{"name":374,"role":48,"phone":375,"phoneExt":24,"email":376},"Cassie Blanchard","267-207-2511","cblanchard@adamsclinical.com",{"name":378,"role":48,"phone":24,"phoneExt":24,"email":379},"Isabel Bear","ibear@adamsclinical.com",{"facility":363,"status":24,"city":381,"state":382,"zip":383,"country":59,"countryCode":60,"cosmosGeoPoint":384,"geoPoint":388,"contacts":389},"DeSoto","Texas","75115",{"type":62,"coordinates":385},[386,387],-96.85695,32.58986,{"lat":387,"lon":386},[390,395],{"name":391,"role":48,"phone":392,"phoneExt":393,"email":394},"Ben Kurian, MD, MPH","972-544-6121","1223","bkurian@adamsclinical.com",{"name":396,"role":48,"phone":397,"phoneExt":398,"email":399},"Jaya Koonjbearry","945-293-7506","1407","jkoonjbearry@adamsclinical.com",{"facility":76,"status":24,"city":401,"state":382,"zip":402,"country":59,"countryCode":60,"cosmosGeoPoint":403,"geoPoint":407,"contacts":408},"Richardson","75080",{"type":62,"coordinates":404},[405,406],-96.72972,32.94818,{"lat":406,"lon":405},[409],{"name":410,"role":48,"phone":411,"phoneExt":24,"email":412},"Scott Bartley, MD","214-396-4844","studies@pillarhc.com",{"type":414,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100621325",false,"NCT07369154","52-week Open Label Safety-Tolerability Study","A 52 Week, Open Label Safety and Tolerability Study of LB-102 in Adult Patients With Schizophrenia","NOVA3","Inclusion Criteria:\n\n* Provide ICF\n* Patients clinically stable PANSS \\\u003C\u002F= 70 at screening\n* CGI-S \\\u003C\u002F+ 3 at screening\n* Medically stable\n* BMI 18 -40\n* Taking oral antipsychotic treatment for at least 30 days\n* Have stable living environment\n\nExclusion Criteria:\n\n* Sexually active M\u002FF patients not willing to use highly effective contraception\n* Breast feeding\n* History of treatment resistance to schizophrenia medications\n* DSM-5 current diagnosis other than schizophrenia\n* Risk of suicidal behavior\n* History or presence of clinically significant cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or oncologic disease or any other","ALL","18 Years","65 Years",{"count":426,"type":427},900,"ESTIMATED","INTERVENTIONAL",[430],"PHASE3","Phase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizophrenia",[433],"Schizophrenia","NOT_YET_RECRUITING","2026-05-13",{"date":437,"type":438},"2026-05-15","ACTUAL",{"date":440,"type":427},"2026-04",{"date":442,"type":427},"2029-04",{"name":5,"class":6},23]